An experimental cancer trial in France is getting a boost from the Gates Foundation: ‘Potential game-changer’
It might eventually lead to an affordable bedside machine that "fully and rapidly" re-arms the immune system.
It might eventually lead to an affordable bedside machine that "fully and rapidly" re-arms the immune system. Read More
